News

Zynex targets $27M Q2 revenue amid restructuring and FDA submission for NiCO
Q1 2025 Management View CEO Thomas Sandgaard addressed the company's challenges, including the temporary payment suspension ...
Zynex, Inc. (ZYXI) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Conference Call April 29, 2025 4:15 PM ETCompany ParticipantsBrian Prenoveau - IRThomas Sandgaard - ...
Business Insider19d
Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit - Hagens Berman
Singh reportedly noted that Tricare, Zynex's largest customer, has temporarily suspended payments amid an ongoing review of prior claims. Singh added that the company's decision to withhold 2025 ...
SHAREHOLDER DEADLINE: Zynex (ZYXI) Investors Are Reminded of Deadline in Securities Action
Philadelphia, Pennsylvania-- (Newsfile Corp. - April 28, 2025) - Berger Montague PC advises investors that a securities class action lawsuit has been filed against Zynex, Inc. ("Zynex" or the "Company ...
WAVY-TV22d
Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit – Hagens Berman
Singh reportedly noted that Tricare, Zynex's largest customer, has temporarily suspended payments amid an ongoing review of prior claims. Singh added that the company's decision to withhold 2025 ...